AGADA CEO Dr. Kanneboyina Nagaraju attended the World Muscle Society Congress Oct 3rd 2018 in Mendoza, Argentina. Dr.Nagaraju presented two posters on Duchenne Muscular Dystrophy
- Vamorolone as a replacement for corticosteroids in Duchenne muscular dystrophy: phase 2a results in 48 DMD boys
- Humoral and cell mediated immune response to new dystrophin after morpholino-induced exon skipping therapy in dystrophin-deficient mdx mice
